Skip to Content

What drugs are contained in Trelegy Ellipta?

Answers (1)

Official Answer by Drugs.com 7 Nov 2017

Trelegy Ellipta is a dry powder inhalation agent that contains fluticasone furoate, umeclidinium, and vilanterol. Trelegy Ellipta is approved for the treatment of patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.

It combines a unique triple therapy; a corticosteroid (fluticasone) with an anticholinergic agent (umeclidinium) and a long-acting beta-2 agonist (vilanterol). It is used for either those on a fixed-dose combination of fluticasone/vilanterol (Breo Ellipta) who need added bronchodilation, or those who are already using Breo Ellipta and Incruse Ellipta (umeclidinium).

Drugs.com free discount card

Further Information

Search for questions

Still looking for answers? Try searching for what you seek or ask your own question.

Frequently Asked Questions

What are the side effects of the flu vaccine?

Updated 13 days ago 1 answerFAQ by Drugs.com

What are the side effects of weed?

Updated 13 days ago 1 answerFAQ by Drugs.com

What are the side effects of radiation therapy?

Updated 12 days ago 1 answerFAQ by Drugs.com

What are the side effects of Molly?

Updated 10 days ago 1 answerFAQ by Drugs.com

What are the side effects of vaping?

Updated 7 days ago 1 answerFAQ by Drugs.com